Pharmaceutical businesses searching for Erlotinib 150 mg Tablets in New York can approach Ernest Oncology for professional oncology sourcing enquiries from India. Our services are designed for eligible pharmaceutical distributors, licensed importers, wholesalers and institutional procurement organisations. Erlotinib 150 mg New York, Erlotinib Tablets New York, Erlotinib 150 mg supplier New York, Erlotinib wholesale supplier, oncology medicine supplier New York, Erlotinib exporter from India.
Understanding Erlotinib 150 mg
Erlotinib is an oral targeted oncology medicine belonging to the EGFR tyrosine kinase inhibitor class. It is used in specific cancer-treatment settings according to approved prescribing information and individual patient characteristics. For certain non-small cell lung cancers, molecular testing plays an important role in determining whether EGFR-targeted treatment is appropriate. Erlotinib is also used in certain pancreatic cancer treatment settings. Treatment decisions are made by qualified oncology doctors.
Erlonat 150 mg and Erlotinib 150 mg Product Information
Erlonat 150 is a branded presentation containing Erlotinib 150 mg. A 30-tablet bottle is an established Erlonat presentation.
Product Detail Information
Medicine Erlotinib
Strength 150 mg
Product Type Oral Tablet
Brand Shown Erlonat 150
Pack Shown 30 Tablets
Therapy Segment Oncology
Drug Class EGFR Tyrosine Kinase Inhibitor
Market Focus New York City
Erlotinib 150 mg Wholesale Enquiries in New York
Depending on current sourcing availability, buyers may enquire about Erlotinib brand options, pack configuration, batch and expiry details, wholesale quantities and available supporting documents.
Erlotinib 150 mg Price and Commercial Quotation
Searches for Erlotinib 150 mg price may show different figures online. Commercial prices can vary according to brand, quantity, packaging and sourcing conditions. Professional buyers should therefore request a current B2B quotation rather than relying on an older advertised Erlotinib price.
Erlotinib Wholesale Enquiries in New York
Buyers researching an Erlotinib 150 mg supplier in New York may submit requirements for available brands, pack configurations, commercial quantities, batch information and supporting documents. Mentioning the exact quantity and preferred packaging helps Ernest Oncology review a wholesale requirement more efficiently.
Ernest Oncology focuses specifically on oncology pharmaceutical sourcing. This gives professional buyers a dedicated channel for enquiries involving targeted cancer therapies and other oncology medicines rather than a general medicine catalogue.Frequently Asked Questions
1. Can New York wholesalers enquire about Erlotinib 150 mg?
Eligible professional buyers can submit commercial requirements for Erlotinib 150 mg, subject to availability and applicable regulations.
2. Is Erlotinib an EGFR inhibitor?
Yes. Erlotinib belongs to the EGFR tyrosine kinase inhibitor class.
3. What information should a New York buyer provide?
Provide the strength, quantity, preferred pack, destination and required documentation.